GT Biopharma annual capital expenditures (capex)
2011
2012
2013
2014
2015
2016
2017
2018
2019
GT Biopharma Capital Expenditures (CapEx) Growth & History (GTBP)
GT Biopharma's capital expenditures (capex) was $0 for fiscal 2019.
View full GT Biopharma company overviewGT Biopharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | $0 | −$36,000 | — |
| 2018 | 2018-12-31 | $36,000 | $32,000 | +800.00% |
| 2017 | 2017-12-31 | $4,000 | $4,000 | — |
| 2016 | 2016-12-31 | $0 | −$1,000 | — |
| 2015 | 2015-12-31 | $1,000 | −$5,000 | −83.33% |
| 2014 | 2014-12-31 | $6,000 | $6,000 | — |
| 2013 | 2013-12-31 | $0 | −$2,000 | — |
| 2012 | 2012-12-31 | $2,000 | $2,000 | — |
| 2011 | 2011-12-31 | $0 | — | — |
GT Biopharma quarterly capital expenditures (capex)
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2019 | 2019-12-31 | $0 | −$32,000 | — |
| Q3 2019 | 2019-09-30 | $0 | −$2,000 | — |
| Q2 2019 | 2019-06-30 | $0 | $0 | — |
| Q1 2019 | 2019-03-31 | $0 | −$2,000 | — |
| Q4 2018 | 2018-12-31 | $32,000 | $28,000 | +700.00% |
| Q3 2018 | 2018-09-30 | $2,000 | $2,000 | — |
| Q2 2018 | 2018-06-30 | $0 | $0 | — |
| Q1 2018 | 2018-03-31 | $2,000 | $2,000 | — |
| Q4 2017 | 2017-12-31 | $4,000 | — | — |
| Q3 2017 | 2017-09-30 | $0 | — | — |
| Q2 2017 | 2017-06-30 | $0 | — | — |
| Q1 2017 | 2017-03-31 | $0 | — | — |
GT Biopharma capital expenditures (capex) trends
Over the last five fiscal years, GT Biopharma's capital expenditures (capex) decreased from $6,000 to $0, a change of −$6,000. The latest reported quarter, Q4 2019, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GT Biopharma source filings ↗